KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Petmed Express (PETS) Invested Capital (2016 - 2025)

Petmed Express has reported Invested Capital over the past 15 years, most recently at $32.8 million for Q4 2025.

  • For Q4 2025, Invested Capital rose 155928.57% year-over-year to $32.8 million; the TTM value through Dec 2025 reached $32.8 million, up 155928.57%, while the annual FY2025 figure was $85.1 million, 405300.0% up from the prior year.
  • Invested Capital for Q4 2025 was $32.8 million at Petmed Express, up from $23.9 million in the prior quarter.
  • Over five years, Invested Capital peaked at $132.5 million in Q2 2021 and troughed at $21000.0 in Q4 2021.
  • A 5-year average of $62.0 million and a median of $77.6 million in 2023 define the central range for Invested Capital.
  • Biggest five-year swings in Invested Capital: soared 546900.0% in 2022 and later plummeted 99.98% in 2024.
  • Year by year, Invested Capital stood at $21000.0 in 2021, then soared by 546900.0% to $114.9 million in 2022, then plummeted by 33.35% to $76.6 million in 2023, then tumbled by 99.97% to $21000.0 in 2024, then surged by 155928.57% to $32.8 million in 2025.
  • Business Quant data shows Invested Capital for PETS at $32.8 million in Q4 2025, $23.9 million in Q3 2025, and $21000.0 in Q2 2025.